URGN
UroGen Pharma Ltd.
NASDAQ · Healthcare · Biotechnology · US
$33.48
−0.80%Leverage
- Debt / equity
- -1.48x
- Net debt / equity
- -0.88x
- Debt / assets
- 0.78x
- Debt / EBITDA
- -2.80x
- Net debt / EBITDA
- -1.67x
Liquidity & coverage
- Current ratio
- 3.80x
- Quick ratio
- 3.41x
- Cash ratio
- 1.74x
- Interest coverage
- -1.93x
- EBITDA / interest
- -2.03x
- Working capital
- $173.5M
Cash & dividend
- FCF / debt
- -0.81x
- Cash flow / debt
- -0.81x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026